The latest immunotherapy news and developments
Cancer drug resistance study raises immune red flags
Sooner or later, most cancer patients develop resistance to the very chemotherapy drugs designed to…
The latest immunotherapy news and developments
Sooner or later, most cancer patients develop resistance to the very chemotherapy drugs designed to…
Cancers whose cells are riddled with large numbers of DNA mutations often respond favourably to…
Immunotherapies have revolutionised treatment for people with a variety of cancers. But when given to…
Using immunotherapy immediately after chemotherapy treatment in patients with metastatic bladder cancer significantly slowed the…
In 2018, approximately 324,000 men died from cancer in the United States. The combination of…
Patients with colon cancer, but no distant metastases yet, can benefit from a short course…
Although metastatic castration-resistant prostate cancer (mCRPC) typically has limited response to immunotherapy, a subset of…
Study showed 93% of patients responded with 67% achieving complete response A one-year follow-up study…
Immunotherapy with genetically modified lymphocytes, such as CAR-T cells, is one of the most promising…
Interleukin-21 plus panobinostat re-program effector cells to a more persistent type of T cell Treating…